<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Approximately 2% of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is linked to pre-existing <z:mp ids='MP_0001845'>inflammation</z:mp> known as <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, but most develops in patients without underlying <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> often follows a genetic pathway whereby loss of the <z:mpath ids='MPATH_271'>adenomatous polyposis coli</z:mpath> (APC) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor and activation of Î²-catenin are followed by mutations in K-Ras, PIK3CA and TP53, as the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> emerges and progresses </plain></SENT>
<SENT sid="2" pm="."><plain>Curiously, however, 'inflammatory signature' genes characteristic of <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> are also upregulated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Further, like most <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumours</z:e>, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> exhibits immune/inflammatory infiltrates, referred to as '<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-elicited <z:mp ids='MP_0001845'>inflammation</z:mp>' </plain></SENT>
<SENT sid="4" pm="."><plain>Although infiltrating CD4(+) T(H)1 cells and CD8(+) cytotoxic T cells constitute a positive prognostic sign in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, myeloid cells and T-helper interleukin (IL)-17-producing (T(H)17) cells promote <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, and a 'T(H)17 expression signature' in stage I/II <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is associated with a drastic decrease in disease-free survival </plain></SENT>
<SENT sid="5" pm="."><plain>Despite its pathogenic importance, the mechanisms responsible for the appearance of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-elicited <z:mp ids='MP_0001845'>inflammation</z:mp> are poorly understood </plain></SENT>
<SENT sid="6" pm="."><plain>Many epithelial <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> develop proximally to microbial communities, which are physically separated from immune cells by an epithelial barrier </plain></SENT>
<SENT sid="7" pm="."><plain>We investigated mechanisms responsible for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-elicited <z:mp ids='MP_0001845'>inflammation</z:mp> in a mouse model of colorectal <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, which, like human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, exhibits upregulation of IL-23 and IL-17 </plain></SENT>
<SENT sid="8" pm="."><plain>Here we show that IL-23 signalling promotes <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e> and progression, and development of a tumoural IL-17 response </plain></SENT>
<SENT sid="9" pm="."><plain>IL-23 is mainly produced by <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-associated myeloid cells that are likely to be activated by microbial products, which penetrate the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> but not adjacent tissue </plain></SENT>
<SENT sid="10" pm="."><plain>Both early and late colorectal <z:hpo ids='HP_0002664'>neoplasms</z:hpo> exhibit defective expression of several barrier proteins </plain></SENT>
<SENT sid="11" pm="."><plain>We propose that barrier deterioration induced by <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal-cancer</z:e>-initiating genetic lesions results in <z:mpath ids='MPATH_270'>adenoma</z:mpath> invasion by microbial products that trigger <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-elicited <z:mp ids='MP_0001845'>inflammation</z:mp>, which in turn drives <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e> </plain></SENT>
</text></document>